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Immune-mediated mesangial cell injury—Biosynthesis and function of
prostanoids. We studied the formation of cyclo-oxygenase products in a
rat model of mesangial cell injury, in order to determine a possible role
of prostaglandin E2 (PGE2), prostaglandin 12 (determined as 6-keto-
PGFI,, and thromboxane A2 (TxA2) in immune-mediated glomerular
disease. Selective immune-mediated mesangial cell injury was induced
by i.v. administration of a rabbit anti-rat thymocyte antiserum (ATS).
Intravenous ATS leads to immune deposits in the mesangium followed
by mesangiolysis and the infiltration of polymorphonuclear granulo-
cytes and monocytes. Glomerular TxB2 formation two hours (292 27
pg/mg/mm) and 48 hours (396 69 pg/mg/mm) following antibody was
significantly (P < 0.05) higher compared to animals receiving non-
antibody rabbit IgG (TxB2: 2 hr 143 13; 48 hr 171 32 pg/mg/mm).
Treatment with cobra venom factor (CVF) and the reduction of
glomerular monocyte infiltration inhibited the increase of glomerular
TxB2 formation significantly, Depletion of granulocytes with a rabbit
anti-rat granulocyte serum had no effect on glomerular prostanoid
formation following ATS. Glomerular POE2 and 6-keto PGF produc-
tion was not altered following ATS. Inulin clearance in rats with
immune-mediated mesangial cell injury was significantly (P < 0.001)
lower at two hours (456 24 pi/min/l00 g body wt) and 48 hours (433
54 dImin/l00 g body wt) compared to their corresponding control
animals which were treated with non-antibody IgG (2 hr: 914 51; 48
hr: 694 79 d/min/l00 g body wt). Pretreatment of rats with indometh-
acm (Indo) or with the thromboxane synthetase inhibitor UK 38485
prevented the decrease in inulin clearance following ATS at two hours
(Indo: 800 67; UK 38485: 923 115) and at 48 hours (Indo: 697 60;
UK 38485: 654 99). The data demonstrate that selective, immune-
mediated mesangial cell injury in rats is associated with increased
glomerular TxB2 formation. Complement and monocyte/macrophage
depletion reduces TxB2 production. The fall in inulin clearance follow-
ing ATS is ameliorated when the rats receive indomethacin or the Tx
synthetase inhibitor UK 38485. Thus, elevated TxB2 formation might
mediate the reduction in GFR in this model of glomerular immune
injury.
Since Lianos, Andres and Dunn [1] observed that the induc-
tion of an immune-mediated glomerular injury stimulates gb-
merular prostanoid formation, several studies demonstrated the
involvement of arachidonic acid metabolites in the pathophys-
iology of glomerular disease [2—8]. The effects of prostaglandins
(PGs), thromboxane A2 (TxA2), and leukotrienes on glomerular
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hemodynamics and proteinuria in immune glomerular injury
seem to be dependent on the type of animal models, the cellular
sources of eicosanoid formation and on the relative pattern of
the diverse cyclooxygenase products formed in the glomerulus.
The hemodynamic consequences in glomerular disease aris-
ing from altered eicosanoid formation are partially explained by
the effects which arachidonic acid metabolites exert on glomer-
ular mesangial cells. Prostaglandins [9], leukotrienes [10, 11]
and thromboxane [12] modulate the contractile properties of
mesangial cells and can mediate glomerular filtration rate due to
changes of the ultrafiltration coefficient [13].
In most animal models where changes in glomerular hemo-
dynamics are attributed to a function of eicosanoids, mesangial
cells were not primary targets of the immune injury. It is
unclear, however, which role eicosanoids might have on gb-
merular hemodynamics, when the mesangial cells are selec-
tively injured by an immune mediated process.
Therefore, we studied prostaglandin E2 (PGE2) and throm-
boxane B2 (TxB2) formation in a rat model of selective immune-
mediated mesangial cell injury. The lesion was induced with a
polycbonal rabbit anti-rat thymocyte antiserum. We also exam-
ined the role of prostanoids on GFR in this model. Our findings
demonstrate that increased TxA2 formation following ATS
depends on an intact complement system and that the stimu-
lated TxA2 biosynthesis mediates the decrease in GFR which
appears in this model of glomerular mesangial cell injury.
Methods
Materials
Male Wistar rats and male Lewis rats, weighing 190 to 210 g
were obtained from Ivanovas (Kisslegg, FRG). 3H-PGE2 and
3H-TxB2 were purchased from DuPont-New England Nuclear
Research products (Dreieich, FRG). PGE2 and TxB2 standards
were purchased from Upjohn (Kalamazoo, Michigan, USA).
Indomethacin was obtained from Sigma Chemicals (Mün-
chen, FRG). UK 38485 was a gift from Pfizer (Karlsruhe, FRG).
Cobra venom factor was obtained from Cordis Laboratories
(Miami, Florida, USA). Antisera to rat C3, rat IgG and rabbit
IgG were from Camon (Wiesbaden, FRG).
mactin was purchased from Byk-Gulden (Konstanz, FRG).
Bolton-Hunter '251-reagent was purchased from DuPont, New
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England Nuclear Research Products. Sephadex G50 was from
Pharmacia (Freiburg, FRG). Inulin was from Sigma Chemicals,
Experimental protocols
All studies followed a similar experimental protocol in which
groups of rats had immune mediated mesangial cell injury. TxB2
and PGE2 were determined in isolated glomeruli at two hours
and/or 48 hours following antibody or non-antibody-rabbit IgG
injection. Renal tissue was obtained at two hours and/or 48
hours after ATS. In the same time intervals, inulin clearances
were determined. The following groups of animals were stud-
ied.
Immune mediated mesangial cell injury (MCI). To assess the
effect of the induction of mesangial cell injury (MCI) on
glomerular PGE2 and TxB2 production, rats received either
anti-thymocyte antiserum (see below) or equal amounts of
non-antibody rabbit IgG. Prostanoid formation in glomeruli was
assessed at two and 48 hours.
MCI and complement depletion. Two groups of rats (N = 7,
each group) were complement depleted with cobra venom
factor (CVF) prior to antibody injection to determine the effect
of glomerular complement activation by immune complex for-
mation on glomerular prostanoids. Two additional groups of
rats (N = 7, each group) received the CVF carrier. MCI animals
(one group with CVF, one group with CVF carrier) received
rabbit anti-thymocyte antiserum (ATS). The remaining two
groups of rats received non-antibody rabbit IgG. Glomerular
prostanoid formation was assessed two hours after antibody.
MCI and polymorphonuclear granulocytes (PMN) depletion.
Two groups of rats (N = 7, each group) were PMN depleted
with a rabbit anti-rat PMN antiserum prior to ATS injection to
assess a possible role of polymorphonuclear granulocytes on
PGE2 and TxB2 formation in glomeruli of rat kidneys with MCI.
Rats with MCI received ATS. Control rats were injected with
non-antibody rabbit IgG. Glomeruli were isolated after two
hours for prostanoid determination and histologic studies.
MCI and monocyte depletion. Two groups of rats (N = 7
each group) were monocyte depleted with a rabbit anti-rat
monocyte antiserum prior to ATS injection in order to evaluate
the possible role of monocytes/macrophages on glomerular
prostanoid and thromboxane B2 formation of rats with MCI.
Since our combined in vivo in vitro studies revealed that
monocytes were present in glomeruli at 48 hours after antibody,
we studied glomerular cyclo-oxygenase production at this time.
Inulin clearance—The effects of indomethacin and UK 38485.
Two groups of rats received ATS to assess the influence of MCI
on inulin clearance. Control animals were treated with non-
antibody rabbit IgG. Inulin clearance was evaluated at two
hours (MCI: N = 7; IgG: N = 7) and 48 hours (MCI: N = 14;
IgG: N = 7). Additional groups of animals received the cyclo-
oxygenase inhibitor indomethacin or the thromboxane syn-
thetase inhibitor UK 38485. Inulin clearance in Indo and UK
treated rats was determined at two hours (Indo: N = 7; UK
38485: N = 7) and 48 hours (Indo: N = 6; UK 38485: N = 7).
Effect of complement and granulocyte depletion and indo-
methacin and UK 38485 on glomerular '251-labelled ATS bind-
ing. Five groups of rats (N = 5, each group) received either no
treatment, CVF, anti-PMN antiserum, indomethacin or UK
38485 to assess whether complement or leucocyte depletion or
the inhibition of cyclo-oxygenase or thromboxane synthetase
might have an effect on ATS binding. Control animals remained
untreated. Two hours after ATS antibody 1251 binding to
isolated glomeruli was assessed.
Experimental procedures
Induction of mesangial cell injury. Selective immune-medi-
ated mesangial cell injury (MCI) was induced in male Wistar
rats (190 to 219 g) by i.v. injection of 5 mg/lOO g body wt of an
IgG preparation of rabbit anti-rat thymocyte antiserum (ATS).
ATS was induced in New Zealand rabbits by repeated immu-
nization with 2 x 108 thymocytes from Lewis rats, combined
with Freund's complete or incomplete adjuvant. The IgG prep-
aration of the rabbit serum was made by caprylic acid precipi-
tation according to the method described by Steinbuch and
Andran [141. Reactivity of the antibody was tested on cultured
mesangial cells grown as previously described [15] by indirect
immunofluorescence.
Radiolabelling of ATS. IgG was labelled with 1251using the
Bolton-Hunter reagent (New England Nuclear, Dreieich, FRG)
in order to study the effect of different interventions (comple-
ment and PMN depletion, cyclo-oxygenase and thromboxane
synthetase inhibition) on ATS-IgG binding on glomeruli in vivo.
Gel filtration (sephadex G 50) was used for separation of
labelled protein from the '251-glycine conjugate. The final
preparation of 125! anti-ATS-IgG was 92% precipitable in 10%
TCA. The specific activity was 4 x iO cpm/jsg protein. The 125j
labelled IgG was mixed with unlabelled ATS-IgG prior to i.v.
injection. Glomeruli from the kidneys were isolated two hours
after '251-labelled ATS IgG and the amount of antibody bound
to glomeruli was assessed according to Salant, Darby and
Couser [16]. Glomeruli were isolated as described below,
counted visually in a Fuchs-Rosenthal hemocytometer and the
amount of '251-labelled antibody was assessed by counting the
glomeruli in gamma-counter (Packard). Results are expressed in
counts/76,000 glomeruli. Seventy-six thousand glomeruli relate
to the total number of two rat kidneys.
PMN depletion. Anti-PMN antiserum was raised in New
Zealand White rabbits by immunization with 2 X 108 Wistar rat
PMNs in complete and incomplete Freund's adjuvant [17]. The
PMNs were collected from rat ascites three to five hours after
instillation of 10 ml of 0.1% oyster-glycogen-heparin HBSS.
Rabbit sera were heat inactivated at 56°C for 90 minutes. An
IgG preparation was made according to Steinbuch and Andran
[141. Ten mg/lOO g body wt of anti-PMN antiserum was given 14
hours before the administration of ATS. PMNs were 64 11
cells/cm after PMN antiserum one hour prior to ATS. The mean
total white cell count of rats without anti-PMN serum was 10800
1470 cells/cm. To determine whether rabbit anti-rat PMN
antiserum had an effect on complement prior to ATS, serum
was collected from all the animals for the determination of
complement CH5O activity.
Complement depletion. Rats were depleted of complement
by injection of cobra venom factor (CVF) according to a
protocol described by Cochrane, MUller-Eberhard, and Alken
[18], to study the effect of mesangial cell immune complex-
induced activation of the complement system on glomerular
prostanoid formation. 300 U/kg/body wt of CVF was given i.p.
the day prior to the antibody. Two hours before antibody
injection the rats received 100 U/kg/body wt/CVF i.p. Prior to
antibody injection and at the end of the experiment (2 hr), blood
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was collected for determination of CH50 activity. CH50 mea-
surements were performed according to the technique of Mayer
[19].
For control of possible effects of CVF alone on glomerular
PG formation, control rats (N = 5) received CVF, however,
they did not receive ATS.
Depletion of glomerular monocytes. Anti-rat monocyte anti-
serum was raised in New Zealand white rabbits by the immu-
nization with io Wistar rat monocytes in complete and incom-
plete Freund's adjuvant. The monocytes were collected from
rat ascites three to four days after the instillation of 10 ml of
10% protease solution. The collected cells were cultured for five
to six hours in RPMJ 1640 + 10% FCS in tissue culture flasks.
The adherent cells were collected and frozen in HBSS at —20°C
until utilized for immunization. Rabbit sera collected after the
third or fourth immunization were heat inactivated at 56°C for
60 minutes. An IgG preparation was made according to Stein-
buch and Andran [14] and the antiserum was tested. The
antibody which was used to deplete monocytes, stained mono-
cytes up to a titer of 1:1000 when evaluated by immunofluores-
cence but did not stain lymphocytes or granulocytes in a titer
above 1:20. The antisera did not deplete significantly total white
cell counts (11,666 980 cells/mm3) in Wistar rats after a 48
hour treatment protocol (3 x 8 mg antiserumllO0 g body wt/day
i.v.) compared to control values prior to the antiserum (11,750
460 cells/mm3). The used antisera, however, depleted total
peripheral blood monocytes from 1.7 0.07% to 0% after the
treatment protocol. The antimonocyte serum did not stain
glomerular epithelial and mesangial cells in culture and on cross
sections from rat kidneys.
The antisera did not prevent glomerular binding of ATS when
evaluated by immunofluorescence. In order to demonstrate the
effectiveness of the antisera to reduce the number of infiltrating
monocytes in the glomerulus of rats with MCI one group of rats
(N = 7) was injected with ATS; a corresponding group of rats
(N 7) received 8 mg/tOO g body wt of antimonocyte serum
two hours prior to ATS and 3 x 8 mg/100 body wt every 12
hours after ATS. Forty-eight hours after ATS glomeruli were
isolated, treated with collagenase and plated on culture glass
chambers (Miles; 100 glomeruli/well) in RPMI 1640 plus 10%
FCS and incubated at 37°C in 5% CO2. After 12 hours in culture
the non-adherent material was decanted and the adherent cells
were stained with anti monocyte serum and evaluated by
indirect immunofluorescence. Four wells from three animals of
each group of rats were counted for positive adherent mono-
cytes.
Isolation and superfusion of glomeruli. Glomeruli were iso-
lated by a sieving technique as described earlier [20]. Glomeruli
were transferred on a millipore filter and superfused for 30
minutes with Krebs-Ringer-HCO3 buffer at 37°C in order to
determine glomerular PGE2 and TxB2 production. The details
of the superfusion technique were described earlier [21]. For
quantification of glomerular protein content glomeruli were
counted in a Fuchs Rosenthal chamber.
Four milliliters of buffer were used as perfusate in a closed
superfusion system at a perfusion rate of 7 mI/mm. The perfu-
sates were collected and frozen at —20°C until analysis for
PGE2 and TxB2. The glomeruli were solubilized in a I N NaOH
and protein analysis was performed according to the method of
Lowry et al [221.
Measurements of PGE2 and TxB2 and 6-keto-PGF1,,. PGE2,
6-keto-PGF1, and TxB2 were determined by direct radioimmu-
noassay in the perfusates without prior extraction or chromato-
graphic separation. Urinary PGE2, 6-keto-PGF1 and TxB,
excretion was determined after the extraction of urines with
ethyl acetate and chromatographic separation on thin layer
chromatography as described earlier [21]. The used assay
procedures, sensitivity and specificity of the PGE2 and TxB2
antisera were described earlier [20, 21]. 6-keto-PGF1, was
measured with a commercially available radioimmunoassay kit
purchased from NEN (Dreieich, FRG). Glomerular prostanoid
production is expressed in pg/mg glomerular protein/mm incu-
bation time.
Inulin clearances—Effect of indomethacin and UK 38485. To
determine the influence of antibody on GFR and inulin, clear-
ances were performed in control rats receiving non-antibody
IgG and animals receiving ATS. Inulin clearances were mea-
sured at two hours and 48 hours after antibody or IgG injection.
The rats were anesthetized with mactin (100 mg/kg/body wt
i.p.). A tracheostomy tube was inserted and both jugular veins
were cannulated with PE-50 polyethylene catheters. The right
ureter was cannulated with a PE-lO polyethylene catheter for
urine collection. Each animal received 10 mI/kg/body wt of a
0.45% saline solution over 10 minutes to replace fluid losses
during surgery. Then a bolus of a 1% inulin solution in 0.45%
saline was given, followed by a 90 minute period where 0.9
mi/hr of a 1% inulin/0.45% saline infusion was given to reach
constant urine flow. Control animals received non antibody
IgG, experimental rats received ATS. I.v. infusion with 1%
inulin in 0.45% saline was continued for two hours. A 30-minute
clearance period followed. Blood for determination of inulin
concentration was collected in the middle of the clearance
period. In animals where GFR was assessed at 48 hours, a
clearance period was determined directly following the 90
minute stabilization interval.
The day prior to antibody, groups of rats received either
indomethacin (5 mg/kg body wt i.v.) or the thromboxane
synthetase inhibitor UK 38485 (50 mg/kg body wt i.v.) to study
a possible role of cyclo-oxygenase metabolites on GFR in rats
with mesangial cell injury. The same dose was given 2 hours
prior to antibody. Indomethacin (2 mg/kg body wt/hr) and UK
38485 (2.3 mg/kg body wt/hr) were continuously infused during
the clearance studies. When inulin clearance was assessed at 48
hours, rats received 50 mg/kg body wt/day of UK 38485 or 5
mg/kg body wt/day of indomethacin in two divided doses orally,
which was given every 12 hours. Inulin was determined accord-
ing to the method of Führ, Kaczmarczyk and KrUttgen [23].
Morphologic studies
Kidney slices were obtained for light-, immuno- and electron-
microscopy. For light- and electron microscopy tissue was fixed
in 4% buffered formaldehyde. For light microscopy tissue was
embedded in paraffin and stained with PAS. For electron
microscopy tissue was embedded in methacrylate. Tissue for
immunofluorescence was snap-frozen in liquid nitrogen, sec-
tioned and stained with IgG fractions of antibodies to rabbit IgG
and rat C3.
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Fig. 1. Two hours following ATS direct immunohistology with anti-
rabbit IgG antibody demonstrates selective staining of the mesangia!
area (A). Indirect immunohistologic staining with rabbit anti-rat C3
antibody was positive in rats receiving ATS (B) (2 hr after ATS),
however, was negative in animals treated with CVF (C) 2 hours after
ATS.
Statistical analysis
All data are given as means SEM. Statistical analysis was
performed with the unpaired Student's r-test with correction for
multiple comparisons when applicable [241. A P value of <0.05
was considered significant.
Results
Morphologic characterization of the immune-mediated
mesangial cell injury
At two hours after antibody injection, glomeruli stained
positive for rabbit IgG and rat C3 (Fig. 1). The staining was
selective and only positive in the mesangial area. The mesangial
cells showed significant degeneration (Fig. 2A) and the mesan-
glum was occasionally infiltrated with PMNs (Fig. 2B). By
electron microscopy there was no evidence for subepithelial or
subendothelial immune deposits.
Forty-eight hours after ATS, immunohistology for rabbit IgG
and rat C3 was negative (not shown). By light microscopy,
glomeruli at 48 hours appeared deprived of mesangial cells and
there were aneurysma-like formations (Fig. 3A) and the appear-
ance of mononuclear cells (Fig. 3B).
'251-labelledATS IgG binding to glomeruli
Table 1 summarizes the 1251-labelled-IgG binding to glomeruli
two hours after antibody injection. Neither complement deple-
tion with CVF nor anti-PMN antiserum significantly influenced
'251-labelled IgG binding to glomeruli. The inhibition of cyclo-
oxygenase with indomethacin and the thromboxane synthetase
inhibitor UK 38485 also did not alter antibody binding to the
glomeruli.
Glomerular prostanoid formation in mesangial cell injury
Glomeruli, isolated from rats with mesangial cell injury two
hours and 48 hours after antibody, produced significantly higher
amounts of TxB2 when compared to glomeruli from rats, which
received non-antibody rabbit IgG (Table 2). Glomerular PGE2
and 6-keto-PGF1 biosynthesis was not different between rats
with MCI and control animals (Table 2). The glomerular protein
content/100 glomeruli averaged 9.08 0.33 jig (2 hr, N = 11)
and 8.11 1.14 jig (48 hr, N = 9) for control rats and 8.08
0.41 jig (2 hr, N 14) and 7.66 0.12 jig (48 hr, N 9) for
animals with MCI.
Effect of complement depletion on MCI
Treatment with CVF reduced complement CH5O activity to
less than 1% compared to animals receiving non-antibody IgG
(50% lysis was found with a dilution of 0.79 0.17; N = 6).
Immunohistologic studies at two hours revealed positive stain-
ing for rabbit IgG, however, glomeruli were negative for rat C3.
The typical morphologic lesions and the cellular influx of PMNs
did not appear. Complement depletion prevented increase in
glomerular TxB2 biosynthesis (150 22, ATS + CVF; Fig. 4)
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Fig. 2. A. The mesangial cells (MC) show degenerative alterations in the cytoplasm 2 hours after ATS. The glomerular basement membrane(GBM), the subendothelial and subepithelial spaces are free of immune deposits (cap = capillary lumen). B. The mesangium was occasionally
infiltrated by polymorphonuclear granulocytes (PMN = polymorphonuclear granulocytes; GBM = glomerular basement membrane; cap =
capillary lumen).
Fig. 3. A. 48hours after ATS, glomeruli were cell depleted and had aneurysm (AN)-like formations. B. 48 hours after antibody mononuclear cells
were present in mesangial areas and capillary lumina (M = mononuclear cells; GBM = glomerular basement membrane; cap = capillary lumen).
which was found in animals receiving ATS alone (326 24). glomeruli to 22 17 cells/l00 cultured glomeruli, when cells
TxB2 production in rats which were complement depleted was were evaluated according to the technique outlined above.
not different from controls which received non-antibody-rabbit Glomerular PGE2 and 6-keto-PGF1 formation was unef-
IgG (168 24 pg/mg/mm; Fig. 4). CVF treatment of normal fected by the treatment with the anti-monocyte serum (Table 3),
control rats (IgG + CVF) did not influence glomerular TxB2 however, glomerular TxB2 formation was significantly reduced
formation (176 36 pg/mg/mm). Complement depletion had no compared to untreated nephritic controls (Table 3). CH5O
effect on glomerular PGE2 formation. complement levels were not significantly reduced, 50% lysis
was found with a dilution of 0.64 0,18 (N = 6).
Effect ofmonocyte depletion on glomerular eicosanoid
formation Effect of PMN depletion on MCI
Treatment of rats with anti-monocyte serum significantly (P Treatment with anti-PMN serum reduced PMNs in the pe-
< 0.001) reduced the number of adherent monocytes/macro- ripheral blood from 2000 214 cells/cmm to 64 11 cells/cmm.
phages of nephritic rats from 145 30 cells/100 cultured Leucocyte depletion did not interfere with '251-anti-thymocyte
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Table 1. '251-labelled rabbit anti-rat-anti-thymocyte IgG binding to rat glomeruli (cpm/76 000 glomeruli)
Non-
antibody
ATS ÷ IgG(N = 5)
ATS + CVF
(N = 5)
ATS + a-PMN-IgG(N = 5)
ATS + indomethacin
(N = 5)
ATS + UK 38485
(N = 5)
16,825
2,495 NS
13,832
3,198 NS
13,790
3,555 NS
15,127
4,290 MS
16,480
4,290 NS
Abbreviations are: CVF, cobra venom factor; a-PMN-IgG, rabbit anti-rat-polymorphonuclear granulocyte antibody; MS = non-significant from
control ATS.
Table 2. Glomerular prostanoid formation in mesangial cell injury
2 Hours 48 Hours
Control
(N = 11)
MCI(N = 14)
Control
(N = 9)
MCI
(N = 9)
TxB2 pg/mg/mm
PGE2 pg/mg/mm
6-keto-PGF1
pg/rn glmin
143 13
311 33
not determined
P < 0.001
NS
292 27
359 66
not determined
171 33
345 45
159 39
P < 0.05
NS
NS
396 60
330 41
219 66
Fig. 4. Glomerular TxB2 formation 2 hours following ATS (N = 7) was
significantly higher when compared with glomeruli of rats receiving IgG(N = 7 *J < 0.001). Cobra venom factor (CVF) treatment of animals
prior to ATS (N = 7) application prevented the increase in glomerular
TxB2 formation seen in ATS animals (**P < 0.001; ATS vs. ATS +
CYF). CVF treatment did not alter TxB2 formation in rats treated with
non-antibody IgG (IgG + CVF, N = 7). Data are given as means SEM.
IgG binding to glomeruli (Table 1) and did not effect comple-
ment CH5O activity (50% lysis with a serum dilution of 0.56
0.13; N = 6). PMN depletion did not significantly reduce TxB2
formation in rats with MC injury when studied two hours after
ATS (ATS: 292 27 pg/mg/mm; ATS + aPMN: 253 40
pg/mg/mm). Glomerular TxB2 production in normal rats receiv-
ing anti-PMN serum was also not effected (aPMN: 134 14
pg/mg/mm), when compared with untreated control rats (108
24 pg/mg/mm).
Inulin clearance in rats with mesangial cell injury—Effects of
indomethacin and UK 38485
Two hours following non-antibody rabbit IgG, GFR was 914
51 .dJlOO g body wt/min and was 784 69 pi/l00 g body
wt/min when rats were studied at 48 hours. Induction of
mesangial cell injury significantly reduced GFR at two hours
(456 24 pJ/100 body wt/min) and at 48 hours (368 40 1.d/100
g body wt/min; Fig. 5). When rats were pretreated either with
the cyclo-oxygenase inhibitor indomethacin or the thrombox-
ane synthetase inhibitor UK 38485, the fall in inulin clearance
Table 3. Effect of glomerular monocyte depletion on prostanoid
formation in rats with mesangial cell injury at 48 hours after antibody
ATS +
monocyte
ATS depletion(N=7) (N=7)
TxB2 394 32 P < 0.05 262 24
pg/rn g/min
PGE2 344 52 NS 424 78
pg/rn gimin
6-keto-PGF1 177 15 NS 213 33
pg/rn gimin
did not appear (2 hr: Indo: 800 67, UK 38485: 923 15; 48 hr:
Indo: 697 60, UK 38485: 654 99 d/100 g body wt/min). The
thromboxane synthetase inhibitor reduced glomerular TxB2
formation in nephritic glomeruli after 48 hours to 59 7
pg/mg/mm (N = 5) versus 396 69 pg/mg/mm, P < 0.001, but
had no significant effect on glomerular PGE2 (350 47 pg/
mg/mm) and 6-keto PGF1 (171 29 pg/mg production, when
evaluated at 48 hr and compared with nephritic untreated
animals; Table 2).
Indomethacin significantly (P < 0.05) reduced glomerular
TxB2 (120 30 pg/mg/mm), PGE2 (183 37 pg/mg/mm) and
6-keto-PGF1 96 20 pg/mg/mm) formation in rats with MCI
after 48 hours, when compared with untreated nephritic rats
(Table 2). UK 38485 reduced urinary TxB2 excretion in ne-
phritic rats from 927 84 pg/30 mm to 127 11 pg/30 mm, but
had no effect on urinary PGE2 (134 17 pg/30 mm) excretion,
when compared to untreated nephritic animals (116 11 pg/30
mm). The cyclo-oxygenase inhibitor indomethacin inhibited
both (P < 0.001) urinary TxB2 (227 42 pg/30 mm) and PGE2
formation in nephritic rats (47 19 pg/30 mm) after the 48 hour
treatment, compared to untreated nephritic animals.
Discussion
The immune glomerular injury which appears in rats after
rabbit anti-rat thymocyte antiserum is morphologically charac-
*
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IgG ATS ATS
+ CVF
NS = not significant
A 2 Hours
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B 48 Hours
Fig. 5. Mesangial cell injury following ATS
reduced the inulin clearance at 2 hours (ATS:
N = 7, IgG: N = 7) and 48 hours (ATS: N =
14, IgG: N = 7) significantly compared with
rats receiving IgG (control IgG). Pretreatment
of rats either with the cyclo-oxygenase
inhibitor indomethacin (ATS + Indo: N = 7)
or the thromboxane synthetase inhibitor UK
38485 (ATS + UK 38485: N = 7) prevented
the fall in the inulin clearance. GFR was not
significantly different from rats receiving IgG.
Data are given as means SaM.
terized by a selective positive immunohistologic staining of the
mesangium for rabbit IgG and rat C3 (Fig. 1). This positive
immunohistology at two hours is associated with the degener-
ation of mesangial cells (Fig. 2A). Electron microscopy re-
vealed that the subendothelial, the subepithelial and the glomer-
ular basement membrane were free of immune deposits (Fig.
2A). At two hours the mesangial area was occasionally infil-
trated by PMNs (Fig. 2B). At 48 hours mononuclear cells
appeared in the glomerular tuft (Fig. 3B). At 48 hours the
severity of the lesion had aggravated and the glomeruli were
still cell depleted with the appearance of microaneurysm (Fig.
3A).
The morphology of this immune glomerular injury is similar
to the model described by Bagchus et al [251 in the Wistar rat
and the lesion reported by Yamamoto and Wilson [26, 27] in the
Lewis rat. Bagchus et al [251 induced the glomerular injury with
a monoclonal antibody which was directed against the Thy-i
antigen, a cell surface antigen on thymocytes which is also
present in a number of different other tissues [28, 29], including
glomerular mesangial cells [30]. The antigenic structures to
which ATS binds on the rat mesangial cells in our animal model
are not yet defined.
The induction of immune mediated mesangial cell injury in
the rat is associated with an increase in TxB2 formation by
isolated glomeruli. TxB2 production was elevated at two hours
and 48 hours after antibody. No difference in glomerular PGE,
and 6-ketO-PGF'ia formation was found between rats with
mesangial cell injury and control rats.
The increase in glomerular production of TxB2 was about
threefold (at 2 hr and 48 hr). The ratio of glomerular PGE2/TxB2
formation in control animals was 3:1 and changed to 1:1
following antibody. The enhanced glomerular TxB2 formation
in the model of mesangial cell injury raises the question
regarding the responsible mechanisms of increased thrombox-
ane formation and the cellular sources which account for the
increased thromboxane production.
There is evidence from recent studies by Chen et al [31] that
an antibody directed against epitopes on mesangial cells stim-
ulates in vitro PGE2 and TxB2 formation in these cells. The
stimulatory effect of the antibody on mesangial cell prostanoid
biosynthesis is amplified when complement is present in the in
vitro system. Earlier studies by Lovett et al [32] demonstrate
that the terminal complement components might be significant
in the stimulation of prostanoids in mesangial cells. Moreover,
we found that glomerular activation of the complement system
stimulated prostanoid formation in a model of membranous
nephropathy [6]. Since Yamamoto et al [26] reported that the
activation of the complement system following anti-thymocyte
antiserum is an important mediator of the degenerative changes
of mesangial cells, we evaluated the relative role of the glomer-
ular activation of complement on the formation of prostanoids
following ATS. When rats were treated with CVF, which
reduced CH5O levels of complement to almost undetectable
levels, the increase in glomerular TxB2 formation did not
appear, which suggests that the activation of the complement
system in the glomerulus is a mediator of elevated glomerular
TxB2 following ATS.
Furthermore, there is additional evidence that monocytes!
macrophages which infiltrate in the glomerulus during the
process of the immune injury might participate in the formation
of thromboxane [3], Therefore, we treated rats with anti-
monocyte serum which reduced monocytes in nephritic rats.
The released amount of TxB,, however, was still higher than
TxB2 formation in non-nephntic controls. These data suggest
that infiltrating monocytes might participate in the elevated
TxB2 formation of this animal model. The infiltration of PMNs
in the mesangium is a prominent histologic feature following
ATS. PMNs can synthesize prostanoids [33] and might in
addition to resident glomerular cells be a source of elevated
thromboxane formation. PMN depletion, however, did not
influence glomerular biosynthesis of TxB2. This makes PMNs
an unlikely source of elevated TxB., production.
Induction of the mesangial cell injury is associated with a fall
of glomerular filtration rate, when the nephritic animals were
compared with rats which received non-antibody rabbit IgG.
The GFR of nephritic rats was about 40% lower than in control
animals. The difference in GFR was present at two hours and at
48 hours. This difference in GFR of control animals might be
due to the experimental protocols. The animals studied at two
hours had a longer pre-equilibration period than rats studied at
48 hours which might have influenced baseline GFR.
The decrease in GFR following ATS was prevented when the
rats were pretreated either with the cyclo-oxygenase inhibitor
indomethacin or the thromboxane synthetase inhibitor UK
C
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38485. Both drugs were used in concentrations which inhibited
intraglomerular prostanoid and thromboxane formation.
The amelioration of the decrease in GFR following indometh-
acm in rats with mesangial cell injury is a rather unexpected
observation. In several other animal models of glomerular
injury we and others found, that indomethacin or other cyclo-
oxygenase inhibitors reduce GFR [2, 7, 34, 35], which suggests
that vasodilatory cyclo-oxygenase products might maintain
GFR in some situations of glomerular disease. In these animal
models, in addition to TxB2, vasodilating prostaglandins were
also enhanced.
Induction of immune-mediated mesangial cell injury, how-
ever, exclusively increases TxB2 formation in isolated glomer-
uli. TxB2 is a vasoconstrictor which might reduce GFR due to
a contraction of mesangial cells [12] and could decrease glomer-
ular plasma flow [36]. The inhibition of this vasoconstnctor by
indomethacin may therefore improve GFR. The observation
that the thromboxane synthetase inhibitor also improves GFR
supports the suggested role for TxB2. Furthermore, the in-
crease in GFR seen at 48 hours following UK 38485 treatment
was higher compared to the effect after indomethacin. This
suggests that vasodilating cyclo-oxygenase products might still
play a role in the regulation of GFR in this state of disease. Our
studies cannot define, however, the hemodynamic factors
which are influenced by TxB2. But recent data by Yamamoto et
al [37] demonstrate a decrease in the Kf in a similar model of
mesangial cell injury.
In summary we conclude that induction of immune-mediated
mesangial cell injury stimulates glomerular TxB2 formation.
This stimulatory effect is dependent on complement activation
and infiltration of monocytes/macrophages in the glomerulus.
The reduction of the glomerular filtration rate following anti-
thymocyte antibody is mediated by TxB2, which makes this
cyclo-oxygenase product a mediator responsible for the de-
crease in GFR in this animal model.
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